Skip to content
Artwork for Pharmacy Podcast Network
NewsBusiness NewsHealth & FitnessMedicineEducation

Pharmacy Podcast Network

Pharmacy Podcast Network

Pharmacy Podcast Network (PPN) is the world’s largest network of podcasts dedicated to the pharmacy professional and industry insiders. Our content is about dynamic people in the pharmacy industry making a difference and delivering the best pharmacy care. We have over 40+ podcasts with thousands of interviews. 

Pharmacists are the cornerstone of healthcare, and the PPN reflects that. From Community, LTC, Specialty Pharmacy to Drug Development, Government policy and DigitalHealth, we cover it all. Partner with us to connect with thousands of daily listeners and find the right pharmacist across various specialties and topics, ensuring your products and services resonate where it matters most. We build strong audio brands through Pharmacists who see patients almost 9x more than primary care.

Join the home of the O.G. Pharmacy Podcast & discover our newest development: Evidence-based Podcasting, the first CME supplement in podcast form that's truly peer-reviewed. The future of podcasting education for Providers is "Evidence-based Podcasting" (TM) and we're building a peer-review board, reach out to us: Publisher @ Pharmacy Podcast dot com. 


PPN is a division of RxPR, LLC. Copyright 2026 

Play
  • 100 episodes
  • daily
  • Avg 40 min
  • English
Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.
  • #2578
    August 31 · 32 min

    More Patients, Same Pharmacists: Preparing Independent Pharmacy for the Next Era of MTM | Outcomes: Insights Beyond the Counter

    As MTM evolves and pharmacies prepare for increased demand, what does success look like from both the technology side and the pharmacy operations side? Ross brings the perspective of innovation, workflow transformation, and MTM Intelligence. Jon brings the perspective of an independent pharmacy owner and operator who understands the realities of staffing shortages, prescription volume, patient expectations, and limited resources. The result is a conversation that feels less like a product discussion and more like an industry discussion about helping independent pharmacies thrive. Guests: Jon Grice and Ross Frei

  • #2576
    August 29 · 42 min

    Inventory, AI and Automation, R&D Tax Credits, Peptides, and Basis | The Bottom Line Rewind

    Schedule an Rx Assessment Welcome everyone to the Bottom Line Rewind, your monthly recap of the Bottom Line Pharmacy Podcast. This month, we feature interviews on topics about Inventory, AI and Automation, the Peptide PCAC meeting, R&D Tax Credits, and Basis when buying a pharmacy. Click below to check out the full episodes: Episode 1: Inventory Management in 2026 with Jared Barton, CEO of Inventory IQ Episode 2: Inside a Pharmacy AI Bot with Ross Miller, VP of Sales at TJM Labs Episode 3: R&D Tax Credit, Trump Accounts, Taylor Swift's Wedding Episode 4: Peptides, Policy, and PBMs with Dr. Anne West, Clinical Pharmacist at Atrium24, Dae Y. Lee, PBM & Pharmacy Practice Group Co-Chair at Buchanan Ingersoll & Rooney, P.C. Episode 5: Understanding Basis When Buying a Pharmacy with Ollin Sykes, CPA, CMA, CITP Stay connected with us: Facebook | Twitter | LinkedIn YouTube | TikTok | Instagram | Blog

  • #2577
    August 28 · 39 min

    Community Pharmacy Freedom, Cash-Based Models & AI-Powered Medication Optimization | TWIRx

    Today’s episode of This Week in Pharmacy — #TWIRx is sponsored by Value Drug Company and explores two major forces reshaping pharmacy: the evolution of the community pharmacy business model and the expanding role of artificial intelligence in medication optimization and value-based care. PART ONE: The Impact of the Cash-based Community Pharmacy Special Guest: Rick Seipp, PharmD President, Value Drug Company Community pharmacy is entering a new era. In Part One, Todd Eury sits down with Rick Seipp, PharmD, President of Value Drug Company, to discuss the continued evolution and expansion of independent community pharmacy and the many different business models emerging across the profession. Independent pharmacy owners are increasingly evaluating new ways to build sustainable businesses while creating greater professional freedom for pharmacists. One of the most interesting developments is the growth of cash-based and cost-plus pharmacy models that reduce or eliminate dependence on traditional insurance reimbursement and PBM-controlled prescription economics. These models can give pharmacy owners greater control over pricing, patient relationships, clinical services and the overall direction of their businesses — while allowing pharmacists to practice with significantly less interference from insurance companies and pharmacy benefit managers. Two pharmacies in the Pittsburgh region are demonstrating how powerful this model can become: Blueberry Pharmacy — Kyle McCormick, PharmD has built Blueberry Pharmacy around a transparent, cash-based model designed to simplify prescription pricing and create a more direct relationship between the pharmacist and patient. Forward Rx Pharmacy — Brandon Antinopoulos, PharmD is another emerging example of how pharmacists can create innovative pharmacy businesses built around transparency, accessibility and freedom from many of the traditional constraints of third-party reimbursement. Todd and Rick discuss what these models mean for the broader independent pharmacy marketplace and why community pharmacy may be moving toward a much more diversified future. Sponsored by Value Drug Company, a pharmacist-led wholesale distribution partner committed to supporting the continued growth and independence of community pharmacy. https://lnkd.in/ehf76qUs PART TWO: AI-Powered Medication Optimization Special Guests: Yoona Kim, PharmD, PhD Co-Founder & CEO, Arine Jenny Behan, PharmD Lead Clinical Pharmacist, Arine In Part Two, #TWIRx shifts from pharmacy business innovation to one of the most important developments occurring in clinical pharmacy: the use of artificial intelligence to optimize medication therapy at scale. Arine is an AI-powered medication optimization platform designed to improve patient outcomes and reduce healthcare costs by helping ensure patients receive the most effective and appropriate medications. Listen to This Week in Pharmacy — TWIRx on the Pharmacy Podcast Network across Apple Podcasts, Spotify, Amazon Music, iHeartRadio, YouTube and all major podcast platforms. Pharmacy Podcast Network — Amplifying the Voice of Pharmacy.

  • #2575
    August 27 · 38 min

    2026 Cencora ThoughtSpot Rewind | Part Three

    Welcome to the 2026 Cencora ThoughtSpot Rewind, sponsored by Outcomes! In this special 4-part series we get a deep look into the event that took place this year in Orlando Florida. The Pharmacy Podcast Network was embedded into the Outcomes booth where we caught all the action on the show room floor. To learn more about what Outcomes is doing for pharmacies, visit https://www.outcomes.com/ In this episode hosted by Todd Eury, Founder and CEO of the Pharmacy Podcast Network, we hear from: Kushal Vaghani - Denbigh Pharmacy Kevin Boesen - Outcomes Gold Eneyo - Cencora Nic Bernabe - Outcomes Steven Dolan - Monroe Pharmacy Dalia Rios - Outcomes Christian Hampel - Family Prescription Counter

  • #2574
    August 26 · 59 min

    Can the Body Heal Itself? A Pharmacist and Naturopath Talk Pregnancy and Nutrition | MaternalRx

    Can the Body Heal Itself? A Pharmacist and Naturopath Talk Pregnancy and Nutrition Dr. Randi Shannon said she was going to blow our minds, and she delivered! In this episode of MaternalRx, pharmacist Danielle Plummer, PharmD, sits down with Dr. Shannon, a traditional naturopath who uses Face, Tongue and Nail Analysis, an approach she describes as rooted in thousands of years of traditional medicine. Their conversation explores pregnancy preparation, nutrition, nausea and vomiting, minerals, essential oils, disease prevention, and Dr. Shannon’s belief that the face, tongue, and fingernails can reveal clues about what is happening inside the body. The interview is followed by a commentary where Danielle puts her pharmacist hat on for an evidence-based debrief, examining several of the episode’s most surprising claims and asking an essential healthcare question: What happens when an idea sounds biologically plausible, yet the clinical evidence has not been tested? Topics include Type 1 diabetes, Down syndrome, salt intake, peppermint oil in pregnancy, cholesterol, dietary oils, pharmaceuticals, nutrient requirements, and the important distinction between traditional naturopaths and licensed naturopathic doctors. This isn’t a conversation about dismissing complementary medicine. It’s about listening with curiosity while still asking important questions: What do we know? What don’t we know? Where might an approach put a patient or pregnancy at risk, and where might it support the body’s ability to heal? Stay through the end to hear Danielle's Takeaway! Section 1: Welcome and disclaimer Meet Dr. Randi Shannon What is a naturopath? Preparing the body for pregnancy Nausea in pregnancy and gut health What can fingernails tell us? Nutrients and claims about preventing or reversing disease What can the tongue reveal? What can the face reveal? Section 2: Evidence-Based Debrief Do we need exactly 60 minerals, 16 vitamins, 12 amino acids and 3 essential fatty acids? Is Type 1 diabetes created during the first trimester? Can Type 1 diabetes develop later in life? Can maternal nutrition reverse Down syndrome in utero? Peanuts, mold, aflatoxins and liver risk Peppermint essential oil during pregnancy Are Americans “undersalted”? Pharmaceuticals, synthetic drugs and side effects Cholesterol, dietary oils and reproductive health Traditional vs. licensed naturopaths Danielle’s takeaway About Dr. Randi Shannon Randi Shannon, ND, is a Florida-based traditional naturopath known for her use of Face, Tongue and Nail Analysis. She works with clients virtually in Florida, across the United States and internationally. Learn more: TheBodyCan.com RandiShannon.com/face-tongue-nail-analysis/ (844) 275-1056 About the Host Danielle Plummer, PharmD, is a pharmacist, antepartum doula, and founder of Obstet-Rx. Also known as HG Pharmacist, she helps women navigate Hyperemesis Gravidarum and medication use in complex pregnancies through education, advocacy and personalized medicine. HGPharmacist.com LinkedIn: linkedin.com/in/daniellerplummer HG Support Group: facebook.com/HGClinicalSolutions Important Listener Note This episode contains health and medical claims made by a guest that may differ from or contradict current evidence-based medical guidance. The guest’s statements represent her perspectives and should not be interpreted as endorsement by MaternalRx, Danielle Plummer, or the Pharmacy Podcast Network. The second half of the episode provides Danielle’s evidence-based commentary on several of these claims. This podcast is for educational purposes and is not a substitute for individualized medical care. Patients should discuss medications, supplements, herbal products, essential oils, and other treatments with an appropriately qualified healthcare professional. TzrIckmic7Yeigg0uagt

  • #2571
    August 24 · 22 min

    Easing Prior Auth Pain Points for Specialty Pharmacies with Develop Health | NASP Specialty Pharmacy Podcast

    In this episode of the NASP Podcast, host Sheila Arquette, President & CEO of NASP, speaks with Nico Kernick, Head of Growth and Operations at Develop Health. They discuss the ways AI is reducing friction and increasing transparency in the prior authorization process for providers and specialty pharmacies. Nico shares how Develop Health's AI-native workflows now support over 3 million patients, boosting submission and first-pass approval rates while keeping providers in control every step of the way. Listeners can expect to learn how pharmacies can get started overnight, plus a special offer for NASP members.

  • #2572
    August 21 · 1 hr 9 min

    Pharmacists and Advocacy for Patients in Pain | TWIRx

    Pharmacists and Advocacy for Patients in Pain Friday, August 21, 2026 What happens when patients living with chronic pain, their advocates, and the pharmacists responsible for dispensing opioid medications view the same healthcare system from very different perspectives? This special episode of This Week in Pharmacy brings together the Doctor Patient Forum’s founders, Claudia A. Merandi and Bev C. Schechtman, with pharmacist and nationally recognized pharmacy advocate Dr. Shane Jerominski, PharmD—better known as “The Accidental Pharmacist.” The discussion follows a wave of social-media debate surrounding Claudia’s use of the term “Harmacists,” which prompted responses from hundreds of pharmacists who felt the label misrepresented their professional responsibilities and the legal restrictions under which they practice. Rather than allow that controversy to deepen the divide, TWIRx created an opportunity for direct, respectful conversation. The purpose of this episode is to help pain-patient advocates better understand the limits pharmacists face when dispensing opioids—and to identify opportunities for pharmacists and patient organizations to advocate together for safe, compassionate and uninterrupted pain care. Five Legal and Supply-Chain Realities Affecting Opioid Dispensing Pharmacists have a federal “corresponding responsibility.” Under 21 CFR §1306.04, a controlled-substance prescription must be issued for a legitimate medical purpose. Pharmacists share legal responsibility with prescribers for determining whether a prescription is valid. Knowingly filling an illegitimate prescription may expose the pharmacist to federal penalties and professional discipline. Review the federal regulation. Schedule II prescriptions must satisfy strict requirements. Federal law generally requires a valid written or compliant electronic prescription before a Schedule II opioid may be dispensed. Emergency oral prescriptions are permitted only under limited conditions and require prescriber follow-up documentation. Schedule II opioid prescriptions cannot be refilled. Under federal law, every additional dispensing generally requires a new prescription. Partial fills are allowed only under specific circumstances, documentation requirements and time limits. Pharmacists cannot simply extend or refill opioid therapy when a patient or prescriber requests it. State laws add another layer of requirements. Depending on the state, pharmacists may have to verify prescriber authority, review prescription-monitoring information, validate electronic or security-form requirements, confirm identification, document partial fills, or comply with state-specific dispensing limitations. For example, California requires controlled-substance prescriptions to meet defined security and validity standards. California Board of Pharmacy guidance. Wholesaler monitoring can restrict a pharmacy’s opioid supply. DEA-registered distributors must identify and report suspicious controlled-substance orders under 21 CFR §1301.74. National wholesalers therefore operate monitoring programs that may delay, limit or suspend shipments based on ordering patterns, geography, drug mix and internal thresholds. These controls are imposed upstream and can leave a pharmacy unable to obtain medication—even when the pharmacist believes a prescription is clinically and legally appropriate. Review the federal distributor requirements. These examples are not exhaustive. Pharmacists must navigate overlapping federal law, DEA requirements, state pharmacy and controlled-substance laws, prescription-monitoring systems, employer policies, payer rules, wholesaler restrictions and professional standards. Requirements also vary by state and by the circumstances surrounding an individual prescription. The Central Question How can pain-patient advocates and pharmacists move beyond blame and work together to address the policies, supply restrictions, staffing conditions and regulatory pressures that can interfere with appropriate care? This conversation explores: Why patients may interpret a refusal or delay as judgment, discrimination or abandonment Why pharmacists cannot treat a valid prescriber signature as automatic authorization to dispense How PDMP and risk-scoring information can influence clinical decisions The effect of corporate policies and wholesaler ordering controls The difference between professional judgment and stigma The communication failures that damage trust between patients, prescribers and pharmacists How advocacy organizations and pharmacists can pursue policy reform together Why patients deserve clear explanations, respectful treatment and continuity-of-care planning How pharmacists can remain vigilant without losing empathy for people living with pain About the Doctor Patient Forum The Doctor Patient Forum, founded by Claudia A. Merandi and Bev C. Schechtman, combines healthcare education, research, digital influence and patient advocacy to address the consequences of opioid-reduction policies and barriers to individualized pain care. Claudia A. Merandi is an advocate and educator whose work contributed to a Rhode Island law protecting access to pain management. Since 2016, she has built a growing national audience while documenting systemic harms experienced by patients and healthcare professionals. Bev C. Schechtman is a researcher, advocate and educator who examines opioid-reduction policies, prescription drug monitoring programs and surveillance technologies such as NarxCare. Her work helps patients understand and navigate an increasingly complex healthcare system. Learn more: The Doctor Patient Forum About Dr. Shane Jerominski, PharmD Dr. Shane Jerominski is a pharmacist, Navy veteran and nationally recognized pharmacy advocate known as “The Accidental Pharmacist.” In 2025, his professional peers selected him as one of the “50 Most Influential People in Pharmacy.” Through his influential social-media platform, Shane combines humor, candid commentary and frontline experience to advocate for safer working conditions, professional unity and meaningful reform throughout pharmacy practice. He is also a co-founder of The Pharmacy Guild and has become a prominent voice for pharmacists and pharmacy technicians nationwide. A Call for Collaborative Advocacy Patients should not be stigmatized because they require pain treatment. Pharmacists should not be vilified for complying with laws and professional obligations that can place their licenses and livelihoods at risk. Progress requires both communities to recognize that many barriers originate beyond the pharmacy counter. Patients, pharmacists, prescribers and advocacy organizations share an interest in policies that protect medication safety without denying appropriate, individualized care. The goal is not to determine which group has suffered more. The goal is to replace mistrust with understanding—and turn that understanding into stronger, unified advocacy. This episode is intended for education and discussion. It does not provide legal or medical advice, and regulatory requirements may differ by jurisdiction and circumstance.

  • #2569
    August 21 · 30 min

    Are You Covered? A Liability Insurance Primer for Compounders | Essential: The Pharmacy Compounding Podcast

    This episode looks at some smart ways to regulate pharmacy when it comes to med spas and pop-up clinics — ways that won’t cut patients off from their meds. We also look at the latest news on the thyroid-extract front, what’s happening with peptide compounding, and a bill in California that could bode well for pharmacists nationwide. Then we talk with Kristen Jones, PharmD, from Pharmacists Mutual about how insurance companies view compounding, and why compounders are taking a bigger risk than they might realize if they’re compounding peptides. Pharmacists Mutual: https://pmuw.com Join APC: a4pc.org/join Stay up to date on these topics and more at: a4pc.org/news

  • #2570
    August 20 · 39 min

    2026 Cencora ThoughtSpot Rewind | Part Two

    Welcome to the 2026 Cencora ThoughtSpot Rewind, sponsored by Outcomes! In this special 4-part series we get a deep look into the event that took place this year in Orlando Florida. The Pharmacy Podcast Network was embedded into the Outcomes booth where we caught all the action on the show room floor. To learn more about what Outcomes is doing for pharmacies, visit https://www.outcomes.com/ In this episode hosted by Todd Eury, Founder and CEO of the Pharmacy Podcast Network, we hear from: Scott Lake - Rx.co Kaley Lester - Outcomes Nicholas Turos - Cencora Janet Parrish - Adair Drug; Colombia, KY Kaushal Patel - Apollo Pharmacy; Savannah, GA Bianca Bradshaw - Elmore Pharmacy; Red Bluff, CA Zackary Levine - Cencora

  • #2568
    August 18 · 23 min

    Maximizing What You Have – Proven Strategies to Boost Revenue from Current Patients | Marketing Vitals

    Growing your pharmacy doesn't always mean finding new patients. It can also mean making the most of the ones you already serve. In this episode, we're joined by our partners AxeRx and Scriptly to share proven strategies for increasing revenue through stronger patient engagement, expanded services, and smarter use of technology to streamline workflows and free up valuable staff time. Tune in for practical insights you can start putting into action today.

  • #2567
    August 17 · 53 min

    TRICARE and the Fight for Military Pharmacy Access | PBM Reform with APCI

    The PBM Reform Podcast, sponsored by APCI, welcomes John Vinson, PharmD, Chief Executive Officer of the Arkansas Pharmacists Association, for a timely conversation with host Greg Reybold about the management of the TRICARE pharmacy benefit. Express Scripts administers pharmacy benefits for TRICARE, the Department of Defense healthcare program serving more than 9 million active-duty service members, military retirees, and family members. In fiscal year 2023 alone, TRICARE spent more than $8 billion on prescription medications. Greg and John examine concerns surrounding Express Scripts’ administration of the program, including shrinking pharmacy networks, reduced patient choice, questionable contractor reporting, specialty-drug delivery oversight, and the consequences for independent and rural pharmacies. A 2025 Government Accountability Office investigation found that: TRICARE’s minimum network requirement fell from 50,000 to 35,000 pharmacies. The network had approximately 13,165 fewer pharmacies in late 2024 than in late 2022. An estimated 380,000 beneficiaries may have been forced to find another pharmacy. The Defense Health Agency relied heavily on contractor-submitted reports that contained inaccuracies. DHA had not consistently audited the data used to evaluate beneficiary access. GAO’s two corrective recommendations remain open as of August 2026, although DHA has begun adding reporting and auditing requirements. The episode also addresses higher 2026 prescription copayments. For most non-active-duty beneficiaries, home-delivery copays are now $14 for generic formulary drugs, $44 for brand-name drugs, and $85 for non-formulary medications. At retail network pharmacies, the corresponding 30-day copays are $16, $48, and $85. Greg and John discuss whether PBM-driven network reductions represent true savings—or simply transfer costs, inconvenience, and access barriers to military families and the community pharmacies serving them. Key discussion points Express Scripts’ role in administering the TRICARE pharmacy benefit Pharmacy network contraction and beneficiary disruption Access challenges facing rural communities and military families Inaccurate contractor data and insufficient federal oversight Specialty-pharmacy delivery and monitoring concerns Rising 2026 copayments and pressure toward mail order Arkansas’ leadership in challenging PBM vertical integration The need for transparency, accountability, adequate reimbursement, and patient choice Important clarification: TRICARE is administered by the Department of Defense and is distinct from healthcare and pharmacy services operated by the Department of Veterans Affairs. Sponsored by APCI — American Pharmacy Cooperative, Inc. Sources: U.S. Government Accountability Office, TRICARE’s 2026 pharmacy-benefit update, official 2026–2027 pharmacy costs.

  • #2566
    August 14 · 34 min

    The Value of a Trusted Wholesaler & Cole’s Act Update | TWIRx

    Independent pharmacies need partners they can trust—and patients need a prescription-drug system that puts access ahead of profits. In this episode of This Week in Pharmacy, Todd Eury welcomes Rick Seipp, PharmD, President of Value Drug Company, to discuss the importance of choosing a dependable wholesale distribution partner. Following Smith Drug Company’s announced operational transition, Value Drug Company is prepared to help affected independent pharmacy owners evaluate their purchasing, distribution and operational needs while developing an orderly transition that protects continuity of service. For more than 90 years, pharmacist-led Value Drug Company has supported community pharmacies through transparent pricing, dependable distribution, collective purchasing power and programs designed to improve efficiency, growth and profitability. Rick explains how the company will provide transition assistance and regional gatherings where pharmacy owners can speak directly with Value Drug Company leadership. The episode also features a follow-up conversation with patient advocate Bil Schmidtknecht about the continuing fight for Cole’s Act. Named in memory of Bil’s son, Cole, the proposed reforms seek to protect patients from unexpected formulary and coverage changes that can suddenly make essential medications unaffordable. “Patients can’t afford more delays, and lives should never be collateral damage in a profit-driven system,” Bil says. The discussion examines PBM accountability, medication affordability and why families must receive meaningful notice before coverage changes place lifesaving treatments beyond their reach. TWIRx News: Week Ending August 14, 2026 Employers Are Moving Away from the “Big Three” PBMs A new employer survey points to growing disruption in the PBM marketplace. Forty-six percent of surveyed employers reported using a PBM outside CVS Caremark, Express Scripts and Optum Rx—up from 37% the previous year. Employers are increasingly seeking transparent pricing, access to claims data and greater control over prescription-drug spending. Read the Axios report FDA Delays Major iPLEDGE Changes Until November The FDA has postponed implementation of updated iPLEDGE REMS requirements from August 8 to November 15, 2026, to allow additional system testing. The forthcoming changes are intended to reduce burdens on patients, pharmacists and prescribers while maintaining safeguards surrounding isotretinoin. Read the FDA iPLEDGE update Episode Resources Value Drug Company transition-support announcement Value Drug Company transition assistance: 1-866-226-1772 Patient Protector Modern Medical Mafia: PBM Reform Pharmacy Podcast Network About the Guests Rick Seipp, PharmD President, Value Drug Company Bil Schmidtknecht Patient advocate and father of Cole Schmidtknecht

  • #2565
    August 13 · 39 min

    2026 Cencora ThoughtSpot Rewind | Part One

    Welcome to the 2026 Cencora ThoughtSpot Rewind, sponsored by Outcomes! In this special 4-part series we get a deep look into the event that took place this year in Orlando Florida. The Pharmacy Podcast Network was embedded into the Outcomes booth where we caught all the action on the show room floor. To learn more about what Outcomes is doing for pharmacies, visit https://www.outcomes.com/ In this episode hosted by Todd Eury, Founder and CEO of the Pharmacy Podcast Network, we hear from: Ross Frei - Outcomes Ana Jimenez - Farmacia Las Americas, West Palm Beach, FL Todd Pendergraft - Broken Arrow Family Drug APA, Broken Arrow, OK Justin Erro - Medzoomer Nick DeSouza - Outcomes Jevic Dunn - Outcomes

  • #2564
    August 12 · 33 min

    Introducing the CurifyLabs Platform | TWIRx Special Series

    In the first episode of this three-part CurifyLabs Podcast Series, we provide a broad overview of the CurifyLabs platform and its role in modernizing personalized medicine and pharmaceutical compounding. The discussion explores how the platform combines digital workflows, automated production technology, and standardized processes to help pharmacies and healthcare organizations improve efficiency, consistency, quality, and scalability. Listeners will learn how CurifyLabs supports the preparation of customized medications while helping pharmacy teams reduce manual complexity, strengthen documentation, and expand access to patient-specific therapies. This opening episode establishes the foundation for the series and examines how technology can help transform the future of pharmaceutical compounding.

  • #2563
    August 11 · 40 min

    The Return to the Wise Body: Hormonal Intelligence and Psychedelic-Informed care for Women with Stephanie Karzon Abrams | The Holistic Pharmacy Podcast

    This was one of the most special podcast episodes I’ve recorded to date, especially since it was the first time it was recorded LIVE! We gathered for GALILEA's Gathering — an intimate evening that brought together clinicians, researchers, founders, and facilitators for a real conversation about the future of women's health. I had the privilege of recording a live interview with neuropharmacologist and GALILEA creator Stephanie Karzon right there in the room, surrounded by people who are genuinely building something new A core focus of our conversation was mapping out why hormones and life stages are important to factor into female care and why they're especially needed for the psychedelic experience, from a biochemical perspective and for the lived experience. A psychedelic-informed lens in women's care has now become non-negotiable; since clients will likely explore these medicines with or without capable practitioners willing to guide them. And let’s face it, current pharmacotherapy isn't enough. Identity and spirituality matter in clinical practice. We need to bring hormone and cycle awareness into practice, as well as the relationship between estrogen, serotonin, glutamate, and psychedelic medicine. Stephanie Karzon Abrams is a clinical neuropharmacologist, founder of Beyond Consulting—powering the integrative and psychedelic medicine spaces by bridging emerging research with clinical practice, and designing clinics and healing centers from the ground up. She serves as Clinical Director at Mystic Health, is an associated prescriber of MDMA and psilocybin therapy under Canada’s SAP, and is the Research Director at the Microdosing Collective non profit. Stephanie believes in the undercurrent of joy and authenticity woven into the fabric of our existence, and thus creates talks and workshops where the human experience is explored through the lenses of science, culture, and celebration. With experience in neurology, intensive care, and medical devices at Johnson & Johnson, she is a recognized leader in innovative healthcare. Her work bridges neuroscience, women’s health, plant medicine, and the healing power of music. A musician, writer, and speaker, Stephanie also builds community through gatherings rooted in music and meaning through her label Public Secret. Connect with Stephanie via: Email: stephaniekarzon@gmail.com Website: Beyond Consulting, Stephanie Karzon Abrams, Galilea Health IG: @steph__k, @galileahealth Linked In: Beyond Consulting WhatsApp: galileahealth.community YouTube: Stephanie Karzon Abrams Gift: Womens Health Toolkit https://drive.google.com/drive/folders/1eiNj8zAaHlPK3CZPLdqh2QInmDrGbCQ2?usp=drive_link Visit https://marinabuksov.com for more holistic content. Music from https://www.purple-planet.com. Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

  • #2561
    August 10 · 23 min

    Moving Beyond a Check-the-Box Model: Talking Specialty Pharmacy Accreditation with ACHC| NASP Specialty Pharmacy Podcast

    In this episode of the NASP Podcast, Sheila Arquette, R.Ph., President & CEO of the National Association of Specialty Pharmacy (NASP), sits down with Dr. Caroline Girardeau, PharmD, MBA, PMP, BCPS, Pharmacy Program Director at the Accreditation Commission for Health Care (ACHC), to explore the evolving specialty pharmacy accreditation landscape. Together, they discuss the scope and value of comprehensive specialty pharmacy accreditation, examining how rigorous accreditation standards help improve patient safety, clinical outcomes, operational excellence, and the overall quality of care. They also highlight how specialty pharmacies can leverage accreditation as more than a requirement for participation in payer or limited distribution networks, using it as a strategic framework to drive continuous quality improvement, strengthen operations, and elevate the patient experience.

  • #2562
    August 7 · 58 min· Video

    The Hidden Cost of Managing Pain Without a Pain Pharmacist | TWIRx

    What happens when patients living with chronic pain do not have a pain pharmacist on their healthcare team? In this episode of This Week in Pharmacy, we explore the hidden clinical, emotional, and financial costs of managing pain without a pharmacist trained in pain management. These pharmacists do far more than review medications—they serve as accessible patient advocates, medication experts, care coordinators, and trusted partners for people navigating the complexities of chronic pain. Segment One: Pharmacists Are the Secret Weapon in Pain Management Special guest host Dr. Sing Ping Chow, PharmD, BCPMP, is joined by Dr. Matthew Hermenau, PharmD, BCPMP, CPh, NBC-HWC, CPT, for an important discussion about pharmacist-led pain management. Together, they examine how pain pharmacists can: Identify medication-related risks and opportunities to improve therapy Help patients balance pain relief, function, safety, and quality of life Collaborate with prescribers and other members of the healthcare team Support individualized, evidence-informed treatment plans Educate and empower patients living with chronic pain Advocate for patients whose concerns may otherwise go unheard Address the whole person—not simply a diagnosis or pain score The conversation reinforces a powerful message: pharmacists are one of healthcare’s most underused resources in chronic pain care. When a pain pharmacist is part of the team, patients gain a knowledgeable advocate who understands medications, listens to their lived experiences, and helps them pursue safer and more effective care. Remembering Dr. Jeffrey Fudin This episode includes a special tribute to the late Dr. Jeffrey Fudin, PharmD, widely regarded as pharmacy’s godfather of pharmacist-led pain management. Dr. Fudin was a pioneering clinician, educator, author, mentor, and tireless advocate for the meaningful inclusion of pharmacists in pain care. His work challenged conventional thinking, elevated the role of the pharmacist, and helped build a path for future generations of pain-management specialists. His influence continues through the pharmacists he mentored, the patients he championed, and the profession he inspired. We honor Dr. Fudin’s legacy and his unwavering belief that people living with pain deserve informed, compassionate, and individualized care. Segment Two: The Nation’s Best Hospital Systems In the second segment, we welcome Chelsey Wen, Senior Health Data Analyst with U.S. News & World Report, to discuss the newly released 2026–2027 Best Hospitals rankings. Chelsey explains how U.S. News evaluates hospital performance and how patients and families can use the findings when making healthcare decisions. The latest assessment evaluated nearly 4,500 hospitals across 14 adult specialties and 23 procedures and conditions. It places increased emphasis on patient outcomes and introduces regional specialty rankings designed to help patients locate complex care closer to home. Explore the 2026–2027 Best Hospitals announcement. link: https://health.usnews.com/best-hospitals Topics include: What it means for a hospital to be nationally ranked or rated “High Performing” The clinical data and patient outcomes considered in the evaluation Changes to the 2026–2027 rankings and methodology The importance of regional rankings and access to specialized care How patients should interpret hospital rankings when choosing where to receive care Sponsored By Today’s episode of This Week in Pharmacy is brought to you by First Databank and Outcomes, pharmacy-technology organizations supporting safer, smarter, and more connected healthcare.

  • #2559
    August 6 · 25 min

    Improving Pharmacy Operations and Building New Clinical Revenue | SuiteCast

    Welcome to SuiteCast, a new podcast sponsored by SuiteRx Pharmacy Technology Platforms, exploring the strategies, technologies, and leadership practices helping pharmacies improve performance, expand patient care, and build sustainable revenue. In this episode, we speak with Betsy P. Reynolds, PharmD, Director of Pharmacy Consulting and Partner at Method Healthcare, and Rodney Whittington, CEO and Partner at Method Healthcare. Betsy and Rodney discuss how pharmacy leaders can identify operational inefficiencies, strengthen internal workflows, and develop clinical care programs that support both better patient outcomes and business growth. The conversation also examines new revenue opportunities within long-term care, geriatric pharmacy services, and pharmacy consulting. Listeners will hear practical insights on evaluating current pharmacy operations, implementing scalable clinical programs, improving staff productivity, and aligning technology with the pharmacy’s strategic goals. Key Discussion Topics Identifying and correcting operational inefficiencies Building sustainable clinical care programs Creating new revenue through pharmacy consulting services Expanding into long-term care and geriatric pharmacy Improving workflow, staffing, and organizational performance Using pharmacy technology to support growth and patient care Preparing pharmacies for changing reimbursement and service models Featured Guests Betsy P. Reynolds, PharmD Director of Pharmacy Consulting and Partner Method Healthcare breynolds@methodhc.com Betsy Reynolds is an experienced pharmacy consultant who helps organizations improve pharmacy operations, develop clinical services, and implement strategies that strengthen financial and patient-care performance. Rodney Whittington CEO and Partner Method Healthcare Rodney Whittington provides strategic leadership and operational expertise to healthcare organizations seeking to improve performance, expand services, and develop sustainable models for growth. Learn more about Method Healthcare at methodhc.com. About SuiteCast SuiteCast, sponsored by SuiteRx Pharmacy Technology Platforms, features pharmacy leaders, technology innovators, and industry experts discussing the tools and strategies shaping the future of pharmacy operations and clinical care.

  • #2560
    August 5 · 22 min

    Talking all things Vaccines with Vaccine Connect | Marketing Vitals

    Vaccines are a key part of an independent pharmacy and clinic's business, but many owners may not be aware of purchasing options, savings opportunities, and ways to maximize their impact. In this episode, Amanda from Vaccine Connect joins us to share insights on all things vaccines, including tips for optimizing your vaccine program and marketing immunizations year-round—not just during flu season.

Showing 61–80 of 100 episodes